Unknown

Dataset Information

0

Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes.

ABSTRACT: Aims:The present study assessed the therapeutic effect of exenatide and metformin as the initial therapy on overweight/obese patients with newly diagnosed type 2 diabetes (T2D). Methods:The prospective, nonrandomized, interventional study enrolled a total of 230 overweight or obese patients with newly diagnosed T2D who were administrated exenatide or metformin hydrochloride for 12 weeks. Results:224/230 patients, including 106 in the exenatide group and 118 in the metformin group, completed the 12-week treatment. Both exenatide and metformin significantly decreased the HbA1c levels in overweight/obese patients with newly diagnosed T2D (all P < 0.05). The reduction in HbA1c and the proportion of patients with HbA1c?

SUBMITTER: Liu J 

PROVIDER: S-EPMC5735665 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes.

Liu Jia J   Hu Yanjin Y   Xu Yuan Y   Jia Yumei Y   Miao Li L   Wang Guang G  

International journal of endocrinology 20171120

<h4>Aims</h4>The present study assessed the therapeutic effect of exenatide and metformin as the initial therapy on overweight/obese patients with newly diagnosed type 2 diabetes (T2D).<h4>Methods</h4>The prospective, nonrandomized, interventional study enrolled a total of 230 overweight or obese patients with newly diagnosed T2D who were administrated exenatide or metformin hydrochloride for 12 weeks.<h4>Results</h4>224/230 patients, including 106 in the exenatide group and 118 in the metformin  ...[more]

Similar Datasets

Unknown Presurgical trial of metformin in overweight and obese patients with newly diagnosed breast cancer.
| S-EPMC4435671 | biostudies-literature
Unknown Lifestyle modification intervention improves glycemic control in Mongolian adults who are overweight or obese with newly diagnosed type 2 diabetes.
| S-EPMC5043476 | biostudies-literature
Unknown Effect of metformin monotherapy on serum lipid profile in statin-naive individuals with newly diagnosed type 2 diabetes mellitus: a cohort study.
| S-EPMC5899882 | biostudies-literature
Unknown Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus.
| S-EPMC8640145 | biostudies-literature
Unknown Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension.
| S-EPMC6708242 | biostudies-literature
Transcriptomics Transcriptome analysis of Newly Diagnosed Type 2 Diabetes Subjects identifies genes to predict Metformin drug Response
2022-06-30 | GSE153315 | GEO
Unknown Monogenic diabetes in overweight and obese youth diagnosed with type 2 diabetes: the TODAY clinical trial.
| S-EPMC5955780 | biostudies-literature
Unknown Short-term combined treatment with exenatide and metformin for overweight/obese women with polycystic ovary syndrome.
| S-EPMC8667970 | biostudies-literature
Unknown Short Course of Insulin Treatment versus Metformin in Newly Diagnosed Patients with Type 2 Diabetes.
| S-EPMC6162821 | biostudies-literature
Unknown The effect of exenatide on fasting bile acids in newly diagnosed type 2 diabetes mellitus patients, a pilot study.
| S-EPMC7296654 | biostudies-literature